| Mrs Krushangi Trivedi, FNP | |
|
1343 N Alma School Rd Ste 205, Chandler, AZ 85224-5903 | |
| (480) 963-1853 | |
| Not Available |
| Full Name | Mrs Krushangi Trivedi |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 1343 N Alma School Rd Ste 205, Chandler, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689150724 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Phoenician Medical Center Inc | 0547169708 | 34 |
News Archive
Octapharma AG recently submitted its Biological License Application for octagam(R) 10% (human normal intravenous immunoglobulin, liquid) to the U.S. Food and Drug Administration (FDA) with the goal of expanding the biopharmaceutical company's U.S. immune globulin therapy portfolio by early 2010. The application was submitted for the treatment of Idiopathic Thrombocytopenic Purpura (ITP), a blood-clotting disorder that can result in excessive bruising and bleeding.
A new machine developed at North Carolina State University makes an animal heart pump much like a live heart after it has been removed from the animal's body, allowing researchers to expedite the development of new tools and techniques for heart surgery.
When you take a medicine you may want the drug to all be released immediately or perhaps more slowly over a longer period of time. If we can make a medicine where we control the release then we can tailor our medicines to release at the exact rate we choose that is best for the patient.
A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer's disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a larger study to further determine its safety and efficacy as a potential disease-modifying strategy.
› Verified 8 days ago
| Entity Name | Phoenician Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891895637 PECOS PAC ID: 0547169708 Enrollment ID: O20040107000237 |
News Archive
Octapharma AG recently submitted its Biological License Application for octagam(R) 10% (human normal intravenous immunoglobulin, liquid) to the U.S. Food and Drug Administration (FDA) with the goal of expanding the biopharmaceutical company's U.S. immune globulin therapy portfolio by early 2010. The application was submitted for the treatment of Idiopathic Thrombocytopenic Purpura (ITP), a blood-clotting disorder that can result in excessive bruising and bleeding.
A new machine developed at North Carolina State University makes an animal heart pump much like a live heart after it has been removed from the animal's body, allowing researchers to expedite the development of new tools and techniques for heart surgery.
When you take a medicine you may want the drug to all be released immediately or perhaps more slowly over a longer period of time. If we can make a medicine where we control the release then we can tailor our medicines to release at the exact rate we choose that is best for the patient.
A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer's disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a larger study to further determine its safety and efficacy as a potential disease-modifying strategy.
› Verified 8 days ago
| Entity Name | Integrated Healthcare Mobile Solutions, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255749982 PECOS PAC ID: 6406076504 Enrollment ID: O20141010002190 |
News Archive
Octapharma AG recently submitted its Biological License Application for octagam(R) 10% (human normal intravenous immunoglobulin, liquid) to the U.S. Food and Drug Administration (FDA) with the goal of expanding the biopharmaceutical company's U.S. immune globulin therapy portfolio by early 2010. The application was submitted for the treatment of Idiopathic Thrombocytopenic Purpura (ITP), a blood-clotting disorder that can result in excessive bruising and bleeding.
A new machine developed at North Carolina State University makes an animal heart pump much like a live heart after it has been removed from the animal's body, allowing researchers to expedite the development of new tools and techniques for heart surgery.
When you take a medicine you may want the drug to all be released immediately or perhaps more slowly over a longer period of time. If we can make a medicine where we control the release then we can tailor our medicines to release at the exact rate we choose that is best for the patient.
A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer's disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a larger study to further determine its safety and efficacy as a potential disease-modifying strategy.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Krushangi Trivedi, FNP 1343 N Alma School Rd, Ste 160, Chandler, AZ 85224-5901 Ph: (480) 963-1853 | Mrs Krushangi Trivedi, FNP 1343 N Alma School Rd Ste 205, Chandler, AZ 85224-5903 Ph: (480) 963-1853 |
News Archive
Octapharma AG recently submitted its Biological License Application for octagam(R) 10% (human normal intravenous immunoglobulin, liquid) to the U.S. Food and Drug Administration (FDA) with the goal of expanding the biopharmaceutical company's U.S. immune globulin therapy portfolio by early 2010. The application was submitted for the treatment of Idiopathic Thrombocytopenic Purpura (ITP), a blood-clotting disorder that can result in excessive bruising and bleeding.
A new machine developed at North Carolina State University makes an animal heart pump much like a live heart after it has been removed from the animal's body, allowing researchers to expedite the development of new tools and techniques for heart surgery.
When you take a medicine you may want the drug to all be released immediately or perhaps more slowly over a longer period of time. If we can make a medicine where we control the release then we can tailor our medicines to release at the exact rate we choose that is best for the patient.
A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer's disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a larger study to further determine its safety and efficacy as a potential disease-modifying strategy.
› Verified 8 days ago
Dr. David Bebawy, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1405 S Alma School Rd, Chandler, AZ 85286 Phone: 480-256-7420 Fax: 480-646-3826 | |
Heidi U Rula, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 685 S Dobson Road, Chandler, AZ 85224 Phone: 480-821-2838 Fax: 480-821-9444 | |
Srilakshmi Settipalli, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 811 S Hamilton St, Chandler, AZ 85225 Phone: 480-344-6100 Fax: 480-344-6101 | |
Lorretta K Mccarthy, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3960 E Riggs Rd, Suite 1, Chandler, AZ 85249 Phone: 480-786-4441 Fax: 480-786-4609 | |
Kurt Henry Steinke, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1343 N Alma School Rd Ste 160, Chandler, AZ 85224 Phone: 480-963-1853 Fax: 480-726-0695 | |
Neha Maheshwari, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1343 N Alma School Rd, 205, Chandler, AZ 85224 Phone: 480-963-1853 | |
Stephan Zehring, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1435 S Alma School Rd, Chandler, AZ 85286 Phone: 480-668-1600 |